Company:  PACIRA PHARMACEUTICALS, I ... (PCRX)
Form Type:  DEF 14A
Filing Date:  4/21/2017 
CIK:  0001396814 
Address:  5 SYLVAN WAY
SUITE 300
 
City, State, Zip:  PARSIPPANY, New Jersey 07054 
Telephone:  973-254-3560 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$35.70  
Change: 
-0.60 (-1.65%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$1.44B
Trade PCRX now with 

© 2017  
Description of Business
Pacira Pharmaceuticals, Inc., a Delaware corporation, is the holding company for our California operating subsidiary of the same name, or Pacira California. In March 2007, we acquired Pacira California from SkyePharma Holdings, Inc., or Skyepharma (referred to in this Annual Report on Form 10-K as the "Acquisition"). Unless the context requires otherwise, references to "Pacira," "we," the "Company," "us" and "our" in this Annual Report on Form 10-K refers to Pacira Pharmaceuticals, Inc., a Delaware corporation, and its subsidiaries. Corporate Information We were incorporated in Delaware under the name Blue Acquisition Corp. in December 2006 and changed our name to Pacira, Inc. in June 2007. In October 2010, we changed our name to Pacira Pharmaceuticals, Inc. Our principal executive offices are located in Parsippany, New Jersey.
Register and access this filing in:     
  FORM DEF 14A
    NOTICE OF 2017 ANNUAL MEETING OF STOCKHOLDERS
    2 OF THE PROXY STATEMENT. THIS WILL ENSURE THE PRESENCE OF A ...
      COMPENSATION TABLE
    BENEFICIAL OWNER OF SHARES HELD IN "STREET NAME?"
    PROPOSAL NO. 1 - ELECTION OF CLASS III DIRECTORS
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
    DIRECTOR COMPENSATION
    PROPOSAL NO. 2 - RATIFICATION OF THE APPOINTMENT OF KPMG LLP ...
    REPORT OF THE AUDIT COMMITTEE
    EXECUTIVE COMPENSATION
    Compensation Committee Report
      OPTIONS AGGREGATE
    PROPOSAL NO. 3 - ADVISORY VOTE TO APPROVE THE COMPENSATION ...
      BENEFICIAL OWNERS
    STOCKHOLDER PROPOSALS
    OTHER MATTERS